๐Ÿ•ต๏ธ Silexion Therapeutics Corp ($SLXN)

SEC insider & ownership activity, last 12 months ยท CIK 2022416 ยท every row links its SEC filing

Over the last 12 months insiders sold $31K with no open-market buying against it. Shirvan Mitchell sold $31K in discretionary trades (Mar). One red-flag 8-K in the window: Delisting notice (3.01), Aug 21, 2026.

Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Feb 2026: net +$0 Mar 2026: net -$31K Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0 Aug 2026: net +$0 Sep 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) ยท 1 seller, $31K (1 lots)

InsiderBuysBoughtSellsSoldLast
Shirvan Mitchell0โ€“ 1$31KMar 26, 2026

5%+ holders

HolderStakeClassScheduleEvent
Moringa Sponsor, LP 25.0% 13DJul 30, 2026 filing โ†—
Moringa Partners Ltd 10.6% 13DJul 30, 2026 filing โ†—
Ilan Levin 10.6% 13DJul 30, 2026 filing โ†—
Intracoastal Capital, LLC 10.0% 13GSep 17, 2025 filing โ†—
Lincoln Alternative Strategies LLC 6.2% 13GSep 15, 2025 filing โ†—
Mitchell P. Kopin exited 13GAug 18, 2026 filing โ†—
Daniel B. Asher exited 13GAug 18, 2026 filing โ†—
Intracoastal Capital LLC exited 13GAug 18, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Delisting notice (3.01)Aug 21, 2026 filing โ†—
Earnings (2.02)Aug 14, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 14, 2026 filing โ†—
Other events (8.01)Aug 13, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 13, 2026 filing โ†—
Material agreement (1.01)Aug 13, 2026 filing โ†—
Other events (8.01)Aug 13, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 13, 2026 filing โ†—
Reg FD disclosure (7.01)Aug 10, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 10, 2026 filing โ†—
Reg FD disclosure (7.01)Aug 4, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 4, 2026 filing โ†—
Other events (8.01)Aug 3, 2026 filing โ†—
Officer/director changes (5.02)Jul 31, 2026 filing โ†—
Reg FD disclosure (7.01)Jul 29, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 29, 2026 filing โ†—
Charter/bylaw changes (5.03)Jul 21, 2026 filing โ†—
Shareholder vote (5.07)Jul 21, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jul 21, 2026 filing โ†—
Material Modifications to Rights of Security Holders (3.03)May 29, 2026 filing โ†—
Charter/bylaw changes (5.03)May 29, 2026 filing โ†—
Other events (8.01)May 29, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 29, 2026 filing โ†—
Other events (8.01)May 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 26, 2026 filing โ†—
Earnings (2.02)May 18, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 18, 2026 filing โ†—
Material agreement (1.01)May 15, 2026 filing โ†—
Unregistered equity sale (3.02)May 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 15, 2026 filing โ†—